Shengli Xue Selected Research

Shengli Xue Research Topics

10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023 - 02/2014
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 07/2014
5	Leukemia 01/2023 - 07/2014
3	Philadelphia Chromosome 10/2023 - 02/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2016
3	Neoplasms (Cancer) 01/2023 - 01/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 01/2022
2	Multiple Myeloma 01/2022 - 10/2013
1	Critical Illness (Critically Ill) 01/2024
1	COVID-19 10/2023
1	Viremia 10/2023
1	Residual Neoplasm 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Blast Crisis (Blast Phase) 01/2023
1	Epstein-Barr Virus Infections 02/2016
1	POEMS Syndrome (Syndrome, POEMS) 12/2009
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

6	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2022
4	venetoclaxIBA 01/2024 - 01/2023
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2016 - 01/2016
2	Therapeutic UsesIBA 10/2013 - 11/2011
1	Core Binding Factors (Core-Binding Factor)IBA 10/2023
1	SteroidsIBA 01/2023
1	Basiliximab FDA Link 01/2023
1	ruxolitinibIBA 01/2023
1	olverembatinibIBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020
1	AclarubicinIBA 12/2020
1	Decitabine FDA Link 12/2020
1	Complementary DNA (cDNA)IBA 03/2018
1	Imatinib Mesylate (Gleevec)FDA Link 02/2014
1	Bortezomib (Velcade)FDA Link 12/2009
1	EndostatinsIBA 01/2003
1	Recombinant ProteinsIBA 01/2003

13	Hematopoietic Stem Cell Transplantation 01/2024 - 10/2013
5	Therapeutics 10/2023 - 02/2014
4	Transplantation 10/2023 - 07/2014
3	Stem Cell Transplantation 10/2023 - 08/2021
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
2	Salvage Therapy 01/2023 - 12/2020
1	Induction Chemotherapy 12/2023
1	Bridge Therapy 01/2023